Measurement time | Assessment | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
In−/exclusion criteria | Verbal consent | Sociodemographic data | Medical history, medication, therapies | M.I.N.I | PHQ-9 (Patient Health Questionnaire) | Written consent | IDS (Inventory of Depressive Symptomatology) | Content and subjective quality of guidance | Documentation AE/SAE | Evaluation of workshop/program + frequency of use | SF-12 (health related life-satisfaction) | INEP (assessment of side effects, adapted; modified for online usage) | CSQ-8 (patient satisfaction, adapted) | |
Online screening | P | P | ||||||||||||
Telephone interview | P | SA | SA | SA | SA | P | ||||||||
T0 | P | P | SA | SA | P | |||||||||
Week 1 | P | SA | P | |||||||||||
Week 2 | P | P | ||||||||||||
T1 | P | P | SA | SA | P | P | P | |||||||
Week 4 | P | SA | P | |||||||||||
Week 5 | P | P | ||||||||||||
T2 | P | P | SA | SA | P | P | P | P | ||||||
T3–3 months | P | P | SA | P | P | |||||||||
T4–6 months | P | P | SA | P | P | |||||||||
T5–12 months | P | P | SA | P | P |